Explainer: What to know about the COVID-19 vaccine for U.S. children
NEW YORK (Reuters) - The U.S. Food and Drug Administration is considering authorizing a COVID-19 vaccine for children aged 5 to 11. The vaccine from Pfizer Inc and BioNTech SE has been available in the United States to kids aged 12 to 15 since May. Read full story
Comments
Post a Comment